Uterine Atony

18 registered clinical trials studyying Uterine Atony — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Pat NCT07217899	University of Michigan	Phase 2
Unknown	Placental Removal Method And Uterine Massage On Preventing Postpartum Hemorrhage NCT06192836	Busra Lekesiz	—
Completed	Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery NCT05027048	Stanford University	Phase 3
Withdrawn	Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sectio NCT03303235	Johns Hopkins University	EARLY_Phase 1
Completed	Calcium Chloride for Prevention of Uterine Atony During Cesarean NCT03867383	Stanford University	Phase 1 / Phase 2
Completed	Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial NCT03584854	Brigham and Women's Hospital	Phase 4
Completed	Exploration and Determination of Genomic Markers Predictive of Uterine Atony NCT03413917	Baylor Research Institute	—
Completed	Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section NCT02780245	Talkha Central Hospital	Phase 4
Withdrawn	An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery NCT02410655	NYU Langone Health	Phase 4
Completed	Novel Approach of Hayman Uterine Compression Sutures for Management of Severe Atonic Postpartum Hemorrhage: Th NCT04690153	Pınar Yalcin bahat	—
Terminated	Cooling the Uterus in C-section After Dysfunctional Labor NCT02910115	Baylor Research Institute	N/A
Completed	Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage NCT02229513	Baylor Research Institute	N/A
Completed	Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section NCT01630187	Laval University	Phase 4
Unknown	ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean NCT01579201	Maisonneuve-Rosemont Hospital	Phase 4
Withdrawn	Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery? NCT01252342	University of Saskatchewan	Phase 4
Completed	Oxytocin And Uterotonic Agent Use For Cesarean Delivery NCT01549223	Brigham and Women's Hospital	Phase 4
Completed	Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT NCT00790062	University of Alabama at Birmingham	Phase 4
Completed	Up-Down Oxytocin Infusion NCT00785395	IWK Health Centre	Phase 4